Date Type Amount Investors Valuation
12/01/07 Series B 2.699M U.S. Venture Partners, Versant Ventures Unknown
03/01/12 Series C 26M Delphi Ventures, Versant Ventures, U.S. Venture Partners, Domain Associates Unknown



Vascular Architects: Vascular Architects develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The… See Company Profile »
Avantec Vascular: Avantec Vascular is dedicated to advancing vascular therapies through innovation. Avantec is a rapidly growing, privately… See Company Profile »

View more details about this company's competitors